U.S. Markets open in 2 hrs 46 mins
  • S&P Futures

    4,170.25
    -6.00 (-0.14%)
     
  • Dow Futures

    34,013.00
    -68.00 (-0.20%)
     
  • Nasdaq Futures

    14,018.00
    -11.50 (-0.08%)
     
  • Russell 2000 Futures

    2,245.00
    -14.00 (-0.62%)
     
  • Crude Oil

    63.13
    0.00 (0.00%)
     
  • Gold

    1,789.50
    +9.30 (+0.52%)
     
  • Silver

    26.23
    +0.12 (+0.48%)
     
  • EUR/USD

    1.2045
    +0.0065 (+0.5420%)
     
  • 10-Yr Bond

    1.5730
    0.0000 (0.00%)
     
  • Vix

    17.09
    +0.52 (+3.14%)
     
  • GBP/USD

    1.3896
    +0.0056 (+0.4044%)
     
  • USD/JPY

    108.1470
    -0.6360 (-0.5846%)
     
  • BTC-USD

    56,347.11
    +1,695.88 (+3.10%)
     
  • CMC Crypto 200

    1,275.71
    -116.00 (-8.33%)
     
  • FTSE 100

    7,036.54
    +17.01 (+0.24%)
     
  • Nikkei 225

    29,685.37
    +2.00 (+0.01%)
     

Astrazeneca to begin Phase 1/2 clinical trials of coronavirus vaccine in Japan

  • Oops!
    Something went wrong.
    Please try again later.
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the NYSE in New York
  • Oops!
    Something went wrong.
    Please try again later.

TOKYO (Reuters) - Astrazeneca said on Friday it is beginning Phase 1/2 clinical trials in Japan of its coronavirus vaccine candidate.

Trials of the vaccine, known as AZD1222, will be conducted at multiple facilities in Japan, targeting 250 subjects, the company said in a release.

The British company is working with Daiichi Sankyo, JCR Pharma and other partners in Japan to make and distribute the vaccine.

(Reporting by Rocky Swift and Chris Gallagher in Tokyo; Editing by Tom Hogue)